Research chemicals, nucleic acids
Total Trials
37
As Lead Sponsor
21
As Collaborator
16
Total Enrollment
5,683
NCT00679328
OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions
Phase: N/A
Role: Lead Sponsor
Start: Feb 29, 1992
Completion: Dec 31, 1999
NCT00679107
A Prospective Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions
Start: Jun 30, 1999
Completion: Jul 31, 2005
NCT00068172
Study of PI-88 in Patients With Advanced Melanoma
Phase: Phase 1/2
Role: Collaborator
Start: Jul 31, 2001
Completion: Jun 30, 2007
NCT00677950
OP-1 Putty for Posterolateral Fusions
Start: Oct 31, 2001
Completion: Nov 30, 2005
NCT00073892
PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma
Start: Jan 31, 2004
NCT00097851
Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)
Phase: Phase 2
Start: Feb 29, 2004
Completion: Jul 31, 2006
NCT00103389
Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Completion: May 31, 2007
NCT00247728
PI-88 in Hepatocellular Carcinoma After Hepatectomy
Start: Jun 30, 2004
Completion: Jun 30, 2008
NCT00130442
Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma
Start: Jun 30, 2005
Completion: Oct 31, 2010
NCT00678171
A Pilot Study to Evaluate an Osteogenic Protein 1 (OP-1) Putty Spinal System and an Autograft Spinal System
Start: Feb 28, 2007
Completion: Mar 31, 2010
NCT00678353
Study of OP-1 Putty in Uninstrumented Posterolateral Fusions
Start: May 31, 2007
Completion: Aug 31, 2007
NCT01007656
A Multiple-Dose Research Study on Safety Evaluation of the GD Antrodia Camphorata in 30 Healthy Adult Subjects
Start: Nov 30, 2009
NCT01217463
The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study
Phase: Phase 3
Start: Nov 30, 2010
Completion: Feb 28, 2013
NCT01134016
Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects
Phase: Phase 1
Start: Dec 31, 2010
Completion: Jun 30, 2013
NCT01217476
The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study
Completion: Mar 31, 2013
NCT01402908
A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection
Start: Aug 31, 2011
Completion: Jan 31, 2015
NCT01675284
A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine
Start: Aug 31, 2012
Completion: May 31, 2013
NCT02047344
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Start: Oct 31, 2013
Completion: Dec 7, 2018
NCT02313233
Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia
Start: Dec 31, 2013
Completion: May 31, 2015
NCT02264730
ClotFoam as an Adjunct to Hemostasis in Abdominal Surgery - Liver Bleeding is Encountered
Start: Jul 31, 2014
NCT02293850
Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma
Start: Oct 31, 2014
Completion: Apr 30, 2021
NCT02719028
Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
Start: May 31, 2016
Completion: Mar 31, 2019
NCT03193515
A Novel Multiplex ELISA Assay for Surveilling Patients with History of Bladder Cancer
Start: Dec 30, 2016
Completion: Feb 28, 2026
NCT03193528
A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer
Completion: Apr 30, 2027
NCT03193541
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
Completion: Dec 30, 2027
NCT03310632
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Start: Dec 1, 2017
Completion: Dec 31, 2024
NCT03622463
A Trial of Antroquinonol in Patients With Atopic Dermatitis
Start: Jul 17, 2018
Completion: Jul 9, 2019
NCT04110873
A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis
Start: Jul 27, 2018
Completion: Jun 25, 2019
NCT03625102
A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B
Start: Aug 1, 2018
Completion: Jun 16, 2023
NCT04112147
A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B
Start: Aug 10, 2018
Completion: Jun 30, 2020
NCT03823352
Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients
Start: Feb 20, 2019
Completion: Dec 31, 2020
NCT04564781
Predicting BCG Response
Start: Sep 18, 2020
NCT04523181
Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients
Start: Oct 15, 2020
Completion: Dec 23, 2021
NCT05394714
A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study
Start: Mar 10, 2022
Completion: Dec 31, 2026
NCT05347342
A Diagnostic for the Early Detection of Bladder Cancer
Start: Apr 29, 2022
Completion: Dec 30, 2026
NCT06730009
Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients
Start: Oct 21, 2024
Completion: Aug 31, 2029
NCT06966089
ExosomeDx in MRI-negative Men With High PSA
Start: Aug 31, 2025
Completion: Aug 31, 2026
Loading map...